Emblem is a compelling company, for me the biggest asset is Stewart....I don't know of another company in this space that has someone with his experience and, I have to assume, obvious pharma connections.
I thought bears might try to take it down, the short update on the Canadian side will be updated tomorrow after the bell, with numbers current to December 30th. Up to Dec 15th 483K (if memory serves) were borrowed and sold short...we shall see if that number increased, I suspect it has.
I haven't seen them putting any news out, but with the spotlight shining on the entire sector there really is no need I don't think, plus they're very well capitalized anyway.
The only way I see a big correction coming is if there's a bear raid, and even then there still might be enough buy side interest to soak up whatever shares shorts borrow and re-sell.
It looks to me like investors are willing to buy and hold here....when the GOC updates its path to full legalization around April demand could increase significantly.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM